BioSpace News Archive

Journal of American Medical Association Publishes Study Conducted at Tennessee Oncology

Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the Stephens Nashville 2019 Investment Conference at the Omni Nashville Hotel in Nashville, TN, on Thursday, November 14, 2019 at 9:00 a.m.

DEXYCU and YUTIQ now available across the VA and on Federal Supply Schedule to benefit U.S. veterans and other government employees

CareDx, Inc., a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces the launch of AlloSure 3.0, the next iteration in continued transplant patient-focused improvements.

Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics.

Upfront purchase price is $75 million with a potential earn-out payment in 2021

Halozyme Therapeutics, Inc. announced strategic actions to reposition the Company with a focus solely on its ENHANZE® drug delivery technology.

Clinical development of COM902 will enable testing the combination treatment with COM701, Compugen’s anti-PVRIG inhibitor

Supplemental Materials Will be Made Available on Alkermes’ Website on Friday, Nov. 8

Children and adolescents living with type 1 diabetes achieved comparable reduction in average blood sugar and similar risk of low blood sugar events with Toujeo® 300 Units/mL compared to insulin glargine 100 Units/mL, according to results presented at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts.